FOXO1 and endometrial carcinoma: In endometrial carcinoma, LINC00261 was reported to inhibit cell proliferation by promoting the expression of forkhead box protein O1 (FOXO1) through a mechanism of reducing the levels of FOXO1-targeted miRNAs [37].